** Shares of Monash IVF Group MVF.AX rise 4.7% to A$1.22
** Stock hits highest level since mid-January
** The fertility services provider posts 1H25 underlying NPAT of A$15.8 million, up 5.5% from previous year
** Co expects to record underlying group NPAT between A$30 million and A$31 million in FY25 compared to A$29.9 million in FY24
** Co posts 1H25 revenue growth of 11.6% to A$10.3 million
** About 810,200 shares change hands, 1.3 times the 30-day average volume of shares
** Stock down 8.3% this year, as of last close
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.